Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. Hace 2 días · Strong When You Need It. COSEAL can withstand postoperative spikes over 5x normal systolic pressure at up to 660 [+/- 150] mmHg, it remains at application site for 7 days and is resorbed in 30 days. 2,3*. *Preclinical data. Results may not correlate to performance in humans.

  2. Hace 2 días · Proven Efficacy and Safety. As the first and only fibrin sealant custom designed for tissue adherence in plastic, reconstructive and burn surgery. 2 ARTISS has been proven safe and effective in pivotal phase 3, multicenter, prospective, randomized clinical studies. 3,4.

  3. Hace 3 días · DEERFIELD, Ill. - 2024-05-23. Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies 2024 Global Healthcare Conference on Wednesday, June 5, 2024. Joel Grade, Baxter's chief financial officer, is scheduled to present at 9:30 a.m. Eastern Time.

  4. Hace 1 día · Our adhesion prevention portfolio can help you make the critical decisions that could mean healthier lives.

    • Seylan Baxter1
    • Seylan Baxter2
    • Seylan Baxter3
    • Seylan Baxter4
    • Seylan Baxter5
  5. Hace 3 días · Existen opciones de tratamiento distintas a la diálisis que debe tener en cuenta. Si cumple los requisitos necesarios, puede considerar someterse a un trasplante renal. Para algunos, un tratamiento conservador sin tratamiento de diálisis puede ser una opción adecuada. Saber más.

  6. Hace 2 días · Education. Baxter's commitment to advancing clinical nutrition extends beyond innovative products. We partner with nutrition thought leaders to offer on-demand education through programs such as iCAN, SMART PN, and Channel ONE.

  7. Hace 2 días · Enhanced Bone Growth. With enhanced micro and macro porosity and ideal silicon content shown to be optimal for bone formation, INDUCTIGRAFT is designed to promote early vascularization, increase cellular activity, and enhance bone growth as demonstrated in in-vitro and in-vivo pre-clinical studies. 1,2,3,*. *Preclinical data.